Mill Creek Life Sciences is the first company to commercialize human platelet lysate for cellular therapy, and is now developing an autologous DCV for GBM. A spin-off out of the Human Cell Therapy Laboratory at the Mayo Clinic in Rochester, MN, Mill Creek has been involved in clinical cellular therapies from the beginning.